Clinical Trial Update: Comparative Study on the Mode of Action of Vicadrostat and Spironolactone on Protein Profiles and Renal Hemodynamic Effects (COMPARE-VS) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial comparing Vicadrostat and spironolactone on protein profiles and renal hemodynamic effects in CKD and cardiovascular disease, currently r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Diseases
• Chronic Kidney Disease
• Heart Failure

Drugs mentioned

• Spironolactone (spironolactone)
• Vicadrostat

Snippet

Sponsor: University Medical Center Groningen | Conditions: CKD, Cardiovascular Diseases | Phase 2 | Status: RECRUITING